AT13387
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AT13387, covering 2018-07-05 to 2024-08-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST [Phase 2]